by Joshua Stewart, Georgia Institute of Technology Credit: Science Advances (2022). DOI: 10.1126/sciadv.add2288 “Closing the loop” has become one of the jargony cliches of the business world. But in the world of cancer immunotherapy, closing the loop could be an innovation that unlocks powerful therapies for hard-to-treat brain cancers called glioblastomas. Researchers at Georgia Tech and Emory...
